pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
HENGRUI PHARMA · news · pharmadog
← back to HENGRUI PHARMA
News mentioning HENGRUI PHARMA
10
stories
19h
Cardiac drug developer Braveheart banks more than $382M in IPO
biopharma dive
7d
BMS CEO Boerner doesn’t ‘feel any compulsion to chase deals’ despite lack of M&A this year
fiercebiotech
22d
Braveheart, Attovia join next wave of biotech IPOs
biopharma dive
Jul 7, 26
Kailera says obesity pill succeeds in late-stage trial in China
biopharma dive
Jul 7, 26
Hengrui, Kailera's GLP-1 pill posts encouraging efficacy but high side effect rates in late-stage China trials
endpoints
Jun 3, 26
House bill aims to crack down on China biotech deals
biopharma dive
May 12, 26
STAT+: Hims’ sales miss as telehealth competition grows
stat
May 12, 26
Bristol Myers, Hengrui join forces in drugmaking alliance worth up to $15.2 billion
biopharma dive
May 12, 26
Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2B
endpoints
May 12, 26
STAT+: Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs
stat
